Related Experiment Video
Updated: Aug 14, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
Renal angiotensin II up-regulation and myofibroblast activation in human membranous nephropathy
Sergio A Mezzano1, Claudio A Aros, Alejandra Droguett
1Division of Nephrology, School of Medicine, Universidad Austral, Valdivia, Chile. smezzano@uach.cl
Background:
The molecular mechanisms of renal injury and fibrosis in proteinuric nephropathies are not completely elucidated but the renin-angiotensin system (RAS) is involved. Idiopathic membranous nephropathy (MN), a proteinuric disease, may progress to renal failure. Our aim was to investigate the localization of RAS components in MN and their correlation with profibrotic parameters and renal injury.
Methods:
Renal biopsies from 20 patients with MN (11 with progressive disease) were studied for the expression of RAS components [angiotensin-converting enzyme (ACE) and angiotensin II (Ang II)] by immunohistochemistry. Transforming growth factor-beta (TGF-beta) and platelet-derived growth factor (PDGF)-BB were studied by by in situ hybridization, and myofibroblast transdifferentiation by alpha-smooth muscle actin (alpha-SMA) staining.
Results:
ACE immunostaining was elevated in tubular cells and appeared in interstitial cells colocalized in alpha-actin-positive cells in progressive disease. Elevated levels of Ang II were observed in tubules and infiltrating interstitial cells. TGF-beta and PDGF mRNAs were up-regulated mainly in cortical tubular epithelial cells in progressive disease (P < 0.01) and correlated with the myofibroblast transdifferentiation (r = 0.8, P < 0.01 for TGF-beta; r = 0.6, P < 0.01 for PDGF). Moreover, in serial sections of progressive cases, the ACE and Ang II over-expression was associated with the tubular expression of these pro-fibrogenic factors, and with the interstitial infiltration and myofibroblast activation.
Conclusion:
Intrarenal RAS is selectively activated in progressive MN. De novo expression of ACE at sites of tubulointerstitial injury suggests that the in situ Ang II generation could participate in tubular TGF-beta up-regulation, epithelial-myofibroblast transdifferentiation, and disease progression. These results suggest a novel role of Ang II in human tubulointerstitial injury.
Insights
The renin-angiotensin system (RAS) is activated in progressive idiopathic membranous nephropathy (MN), contributing to kidney injury. This study shows angiotensin II (Ang II) may drive fibrosis and disease progression in MN.
Area of Science:
- Nephrology
- Molecular Biology
- Pathology
Background:
- The molecular basis of renal injury and fibrosis in proteinuric nephropathies, such as idiopathic membranous nephropathy (MN), remains incompletely understood.
- The renin-angiotensin system (RAS) is implicated in these processes, and MN can lead to kidney failure.
Purpose of the Study:
- To investigate the localization of RAS components in MN kidney biopsies.
- To correlate RAS component expression with profibrotic markers and indicators of renal injury.
Main Methods:
- Immunohistochemistry was used to assess angiotensin-converting enzyme (ACE) and angiotensin II (Ang II) expression in 20 MN patient biopsies.
- In situ hybridization detected transforming growth factor-beta (TGF-beta) and platelet-derived growth factor (PDGF)-BB mRNA, while alpha-smooth muscle actin (alpha-SMA) staining identified myofibroblast transdifferentiation.
Main Results:
- Elevated ACE and Ang II levels were observed in tubular and interstitial cells, particularly in progressive MN cases.
- TGF-beta and PDGF mRNA were upregulated in tubular epithelial cells in progressive MN and correlated with myofibroblast activation (alpha-SMA).
- Overexpression of ACE and Ang II was associated with tubular profibrotic factor expression and interstitial myofibroblast activation.
Conclusions:
- The intrarenal RAS is selectively activated in progressive MN.
- De novo ACE expression suggests in situ Ang II generation contributes to TGF-beta upregulation, epithelial-myofibroblast transdifferentiation, and disease progression.
- Angiotensin II plays a novel role in human tubulointerstitial injury in MN.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology
Acute Kidney Injury II: Pathophysiology
Diabetic Nephropathy

